2021
DOI: 10.1007/s10815-020-02017-9
|View full text |Cite
|
Sign up to set email alerts
|

Regulating reproductive genetic services: dealing with spiral-shaped processes and techno-scientific imaginaries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 69 publications
0
1
0
Order By: Relevance
“…For example, the FDA could provide oversight related to the accuracy of results and mosaicism, the indication of PGT-A as a medical necessity vs for personal and social reasons, and provide guidelines for developing and implementing patient education. Oversight from a designated federal agency would include detailed guidance for the selection of appropriate new procedures, methodologies, and laboratory requirements, reducing uncertainty as to the risks and benefits of the procedure [ 35 ]. Additionally, health professional organizations need to produce clear guidelines before a new test can be used in the clinic.…”
Section: Discussionmentioning
confidence: 99%
“…For example, the FDA could provide oversight related to the accuracy of results and mosaicism, the indication of PGT-A as a medical necessity vs for personal and social reasons, and provide guidelines for developing and implementing patient education. Oversight from a designated federal agency would include detailed guidance for the selection of appropriate new procedures, methodologies, and laboratory requirements, reducing uncertainty as to the risks and benefits of the procedure [ 35 ]. Additionally, health professional organizations need to produce clear guidelines before a new test can be used in the clinic.…”
Section: Discussionmentioning
confidence: 99%